Sirion
USAWho owns Sirion?
Sirion is an American Biotech company, now owned by PerkinElmer, which acquired it in 2021 from Bayern Kapital.
Brookfield Asset Management is still listed as an investor in Sirion, status not confirmed after the 2021 sale.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods
Bayern Kapital sold Sirion to PerkinElmer in 2021 after 15 years.
More from Brookfield Growth Fund
Other portfolio companies in the same fund.
More PE-backed in SaaS
Comparable saas deals from other GPs.
UK
Ireland
Belgium
Questions
Who owns Sirion?
Sirion is now owned by PerkinElmer, which acquired it in 2021 from Bayern Kapital. Brookfield Asset Management is still listed as an investor in Sirion, status not confirmed after the 2021 sale.
When did PerkinElmer acquire Sirion?
PerkinElmer acquired Sirion in 2021, buying from Bayern Kapital.
Who did Sirion sell to?
Bayern Kapital sold Sirion to PerkinElmer in 2021 (Trade Sale).
Who has owned Sirion over time?
Sirion has been through 2 private-equity ownership periods: Bayern Kapital · via Seedfonds Bayern · 2006–2021 · sold to PerkinElmer · (Trade Sale); Brookfield Asset Management · via Brookfield Growth Fund.